Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
International Journal of Medical Informatics|March 4, 2018
Agent-based computational models to explore diffusion of medical innovations among cardiologistsRaul A Borracci, Mariano A GiorgiVascular Health and Risk Management|September 14, 2012
Rivaroxaban in atrial fibrillationMariano A Giorgi, Lucas San MiguelExpert Opinion on Pharmacotherapy|September 11, 2010
Nonresponders to clopidogrel: pharmacokinetics and interactions involvedMariano A Giorgi, Guillermo Di Girolamo, Claudio D GonzálezCurrent Drug Safety|March 10, 2010
QT interval prolongation: preclinical and clinical testing arrhythmogenesis in drugs and regulatory implicationsMariano A Giorgi, Ricardo Bolaños, Claudio Daniel Gonzalez, et al.Expert Opinion on Pharmacotherapy|May 17, 2011
Pharmacogenomics and adverse drug reactions: the case of statinsMariano A Giorgi, Christian Caroli, Hernán Cohen Arazi, et al.Expert Opinion on Pharmacotherapy|January 25, 2011
Changing anticoagulant paradigms for atrial fibrillation: dabigatran, apixaban and rivaroxabanMariano A Giorgi, Hernán Cohen Arazi, Claudio D Gonzalez, et al.Expert Opinion on Pharmacotherapy|January 25, 2011
Beyond efficacy: pharmacokinetic differences between clopidogrel, prasugrel and ticagrelorMariano A Giorgi, Hernán Cohen Arazi, Claudio D Gonzalez, et al.Medicina|January 8, 2010
[Medical students' attitudes regarding professional practice]Raúl A Borracci, Roberto D Pittaluga, Diego Manente, et al.Revista Panamericana De Salud Publica = Pan American Journal of Public Health|September 4, 2008
Perception of consultation length in cardiology and its ethical implicationsHernan C Doval, Raul Alfredo Borracci, Victor D Darú, et al.Medicina|October 24, 2012
[Patients' preferences for information in health care decision-making]Raúl A Borracci, Diego Manente, Mariano A Giorgi, et al.Pageof 2